Emerging role of Toll-like receptors in the control of pain and itch

Neuroscience Bulletin

Volumn 28, Issue 2, 2012, Pages 131-144

  Liu, Tong ^a   Gao, Yong Jing ^a,b   Ji, Ru Rong ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NANTONG UNIVERSITY   (China)

Author keywords

Astrocytes; Danger associated molecular patterns; Itch; Microglia; Pain; Pathogen associated molecular patterns; Toll like receptor

Indexed keywords

DANGER ASSOCIATED MOLECULAR PATTERN; HISTAMINE; PATHOGEN ASSOCIATED MOLECULAR PATTERN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 11; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

ASTROCYTE; CELL ACTIVATION; CELL STRESS; CELLULAR DISTRIBUTION; DISEASE ASSOCIATION; DISEASE CONTROL; HUMAN; INFLAMMATORY PAIN; INNATE IMMUNITY; INTRACELLULAR SIGNALING; MICROGLIA; NERVE EXCITABILITY; NEUROPATHIC PAIN; NONHUMAN; PAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PRURITUS; REVIEW; SENSORY NERVE CELL; TISSUE INJURY;

ANIMALS; CHRONIC PAIN; GANGLIA, SPINAL; HUMANS; POSTERIOR HORN CELLS; PRURITUS; TOLL-LIKE RECEPTORS;

EID: 84862776778     PISSN: 16737067     EISSN: 19958218     Source Type: Journal    
DOI: 10.1007/s12264-012-1219-5     Document Type: Review

References (149)

1. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124: 783-801. (Pubitemid 43261452)
2. Mills KH. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol 2011, 11: 807-822.
3. Anderson KV, Jurgens G, Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 1985, 42: 779-789. (Pubitemid 16083719)
4. Lemaitre B, Nicolas E, Michaut L, Reichhart JM, Hoffmann JA. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 1996, 86: 973-983. (Pubitemid 26336801)
5. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000, 173: 89-97. (Pubitemid 30095213)
6. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 2010, 11: 373-384.
7. Oosting M, Ter HH, Sturm P, Adema GJ, Kullberg BJ, van der Meer JW, et al. TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoS One 2011, 6: e25998.
8. Triantafilou M, Uddin A, Maher S, Charalambous N, Hamm TS, Alsumaiti A, et al. Anthrax toxin evades Toll-like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers. Cell Microbiol 2007, 9: 2880-2892. (Pubitemid 350066572)
9. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, Schoen RT, et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1-and TLR2-deficient mice. Nat Med 2002, 8: 878-884.
10. Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol 2002, 169: 6668-6672. (Pubitemid 36899248)
11. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 2004, 303: 1529-1531. (Pubitemid 38314425)
12. Town T, Jeng D, Alexopoulou L, Tan J, Flavell RA. Microglia recognize double-stranded RNA via TLR3. J Immunol 2006, 176: 3804-3812. (Pubitemid 43364029)
13. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413: 732-738. (Pubitemid 33009951)
14. Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 2004, 303: 1526-1529. (Pubitemid 38314424)
15. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999, 189: 1777-1782. (Pubitemid 29272694)
16. Poltorak A, He X, Smirnova I, Liu MY, Van HC, Du X, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282: 2085-2088. (Pubitemid 29001265)
17. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001, 410: 1099-1103. (Pubitemid 32391041)
18. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408: 740-745. (Pubitemid 32015992)
19. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol 2002, 20: 709-760. (Pubitemid 34293438)
20. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 2005, 308: 1626-1629. (Pubitemid 40807512)
21. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 2001, 276: 10229-10233.
22. Imai Y, Kuba K, Neely GG, Yaghubian-Malhami R, Perkmann T, van LG, et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133: 235-249. (Pubitemid 351512299)
23. Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 2005, 11: 1173-1179. (Pubitemid 43093664)
24. Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med 2009, 15: 774-780.
25. West XZ, Malinin NL, Merkulova AA, Tischenko M, Kerr BA, Borden EC, et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature 2010, 467: 972-976.
26. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Tolllike receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007, 8: 487-496. (Pubitemid 46605917)
27. Biragyn A, Ruffini PA, Leifer CA, Klyushnenkova E, Shakhov A, Chertov O, et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 2002, 298: 1025-1029. (Pubitemid 35247310)
28. Vabulas RM, Wagner H, Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol 2002, 270: 169-184. (Pubitemid 35448160)
29. Kariko K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem 2004, 279: 12542-12550. (Pubitemid 38445825)
30. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140: 805-820.
31. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol 2004, 4: 499-511. (Pubitemid 38931765)
32. Gao YJ, Zhang L, Samad OA, Suter MR, Yasuhiko K, Xu ZZ, et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci 2009, 29: 4096-4108.
33. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004, 16: 3-9. (Pubitemid 38147427)
34. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003, 301: 640-643. (Pubitemid 36927946)
35. Okun E, Griffioen KJ, Mattson MP. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci 2011, 34 (5): 269-281.
36. Buchanan MM, Hutchinson M, Watkins LR, Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem 2010, 114: 13-27.
37. Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia 2010, 58: 253-263.
38. van Noort JM, Bsibsi M. Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res 2009, 175: 139-148.
39. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009, 139: 267-284.
40. Nicotra L, Loram LC, Watkins LR, Hutchinson MR. Toll-like receptors in chronic pain. Exp Neurol 2011.[Epub ahead of print]
41. Suh HS, Brosnan CF, Lee SC. Toll-like receptors in CNS viral infections. Curr Top Microbiol Immunol 2009, 336: 63-81.
42. Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro M.A., Lizasoain I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation 2007, 115: 1599-1608. (Pubitemid 46648645)
43. Tahara K, Kim HD, Jin JJ, Maxwell JA, Li L, Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain 2006, 129: 3006-3019. (Pubitemid 44684521)
44. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 2006, 116: 456-464. (Pubitemid 43228363)
45. Kim D, Lee S, Lee SJ. Toll-like receptors in peripheral nerve injury and neuropathic pain. Curr Top Microbiol Immunol 2009, 336: 169-186.
46. Guo LH, Schluesener HJ. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci 2007, 64: 1128-1136. (Pubitemid 46684548)
47. Tanga FY, Nutile-McMenemy N, Deleo JA. The CNS role of Tolllike receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 2005, 102: 5856-5861. (Pubitemid 40559649)
48. Kim D, Kim MA, Cho IH, Kim MS, Lee S, Jo EK, et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem 2007, 282: 14975-14983. (Pubitemid 47093373)
49. Obata K, Katsura H, Miyoshi K, Kondo T, Yamanaka H, Kobayashi K, et al. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem 2008, 105: 2249-2259. (Pubitemid 351782279)
50. Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci 2011, 31: 15450-15454.
51. Saito O, Svensson CI, Buczynski MW, Wegner K, Hua XY, Codeluppi S, et al. Spinal glial TLR4-mediated nociception and production of prostaglandin E (2) and TNF. Br J Pharmacol 2010, 160: 1754-1764.
52. Mei XP, Zhou Y, Wang W, Tang J, Wang W, Zhang H, et al. Ketamine depresses Toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain. Neurosignals 2011, 19: 44-53.
53. Christianson CA, Dumlao DS, Stokes JA, Dennis EA, Svensson CI, Corr M, et al. Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Pain 2011, 152: 2881-2891.
54. Wu FX, Bian JJ, Miao XR, Huang SD, Xu XW, Gong DJ, et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci 2010, 7: 251-259.
55. Lan LS, Ping YJ, Na WL, Miao J, Cheng QQ, Ni MZ, et al. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain 2010, 6: 2.
56. Kuang X, Huang Y, Gu HF, Zu XY, Zou WY, Song ZB, et al. Effects of intrathecal epigallocatechin gallate, an inhibitor of Tolllike receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol 2012, 676: 51-56.
57. Qi J, Buzas K, Fan H, Cohen JI, Wang K, Mont E, et al. Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol 2011, 186: 6417-6426.
58. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A 2002, 99: 8360-8365. (Pubitemid 34651057)
59. Hokfelt T, Zhang X, Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci 1994, 17: 22-30. (Pubitemid 24024322)
60. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science 2000, 288: 1765-1769.
61. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 2003, 26: 696-705.
62. Tao YX. Dorsal horn alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking in inflammatory pain. Anesthesiology 2010, 112: 1259-1265.
63. Stucky CL, Gold MS, Zhang X. Mechanisms of pain. Proc Natl Acad Sci U S A 2001, 98: 11845-11846. (Pubitemid 32959788)
64. Luo F, Wang JY. Neuronal nociceptive responses in thalamocortical pathways. Neurosci Bull 2009, 25: 289-295.
65. Liu MG, Chen J. Roles of the hippocampal formation in pain information processing. Neurosci Bull 2009, 25: 237-266.
66. Li HL, Qin LY, Wan Y. Astrocyte: a new star in pain research. Sheng Li Ke Xue Jin Zhan 2003, 34: 45-48.
67. Liu FY, Sun YN, Wang FT, Li Q, Su L, Zhao ZF, et al. Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation. Brain Res 2012, 1427: 65-77.
68. Suter MR, Wen YR, Decosterd I, Ji RR. Do glial cells control pain? Neuron Glia Biol 2007, 3: 255-268.
69. Ji RR, Suter MR. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain 2007, 3: 33.
70. Gao YJ, Ji RR. Targeting astrocyte signaling for chronic pain. Neurotherapeutics 2010, 7: 482-493.
71. Gao YJ, Ji RR. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther 2010, 126: 56-68.
72. Watkins LR, Hutchinson MR, Rice KC, Maier SF. The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci 2009, 30: 581-591.
73. Romero-Sandoval EA, Horvath RJ, Deleo JA. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs 2008, 9: 726-734. (Pubitemid 351950869)
74. Zhang FY, Wan Y, Zhang ZK, Light AR, Fu KY. Peripheral formalin injection induces long-lasting increases in cyclooxygenase 1 expression by microglia in the spinal cord. J Pain 2007, 8: 110-117. (Pubitemid 46186156)
75. Ren K, Dubner R. Interactions between the immune and nervous systems in pain. Nat Med 2010, 16: 1267-1276.
76. Scholz J, Woolf CJ. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci 2007, 10: 1361-1368. (Pubitemid 350014681)
77. Tsuda M, Inoue K, Salter MW. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci 2005, 28: 101-107. (Pubitemid 40178927)
78. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27: 6006-6018. (Pubitemid 46849761)
79. Smith HS. Activated microglia in nociception. Pain Physician 2010, 13: 295-304.
80. Zhou D, Chen ML, Zhang YQ, Zhao ZQ. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci 2010, 30: 8042-8047.
81. Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39: 281-286. (Pubitemid 32186379)
82. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60: 135-148.
83. Zhou LJ, Yang T, Wei X, Liu Y, Xin WJ, Chen Y, et al. Brainderived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat. Brain Behav Immun 2011, 25: 322-334.
84. Xu JT, Xin WJ, Wei XH, Wu CY, Ge YX, Liu YL, et al. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp Neurol 2007, 204: 355-365.
85. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28: 5189-5194.
86. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438: 1017-1021. (Pubitemid 43093974)
87. Li J, Xie W, Zhang JM, Baccei ML. Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-alpha. Mol Pain 2009, 5: 10.
88. Zhou LJ, Zhong Y, Ren WJ, Li YY, Zhang T, Liu XG. BDNF induces late-phase LTP of C-fiber evoked field potentials in rat spinal dorsal horn. Exp Neurol 2008, 212: 507-514.
89. Liu YL, Zhou LJ, Hu NW, Xu JT, Wu CY, Zhang T, et al. Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 2007, 52: 708-715. (Pubitemid 46227465)
90. Park CK, Lu N, Xu ZZ, Liu T, Serhan CN, Ji RR. Resolving TRPV1-and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 2011, 31: 15072-15085.
91. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002, 61: 1013-1021. (Pubitemid 35278723)
92. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173: 3916-3924. (Pubitemid 39280755)
93. Iliev AI, Stringaris AK, Nau R, Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 2004, 18: 412-414.
94. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, et al. Immunostimulatory CpG-DNA activates murine microglia. J Immunol 2002, 168: 4854-4863. (Pubitemid 34495946)
95. Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 2010, 58: 650-664.
96. Qin L, Li G, Qian X, Liu Y, Wu X, Liu B, et al. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPSinduced microglia activation. Glia 2005, 52: 78-84. (Pubitemid 41532140)
97. Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci 2010, 30: 573-582.
98. Sugama S, Takenouchi T, Fujita M, Conti B, Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 2009, 207: 24-31.
99. Cao L, Tanga FY, Deleo JA. The contributing role of CD14 in tolllike receptor 4 dependent neuropathic pain. Neuroscience 2009, 158: 896-903.
100. Raghavendra V, Tanga FY, Deleo JA. Complete Freunds adjuvantinduced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 2004, 20: 467-473. (Pubitemid 38969631)
101. Wen YR, Tan PH, Cheng JK, Liu YC, Ji RR. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc 2011, 110: 487-494.
102. Matsui T, Svensson CI, Hirata Y, Mizobata K, Hua XY, Yaksh TL. Release of prostaglandin E (2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth Analg 2010, 111: 554-560.
103. Dityatev A, Rusakov DA. Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol 2011, 21: 353-359.
104. Petzold GC, Murthy VN. Role of astrocytes in neurovascular coupling. Neuron 2011, 71: 782-797.
105. Gao YJ, Ji RR. Activation of JNK pathway in persistent pain. Neurosci Lett 2008, 437: 180-183.
106. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2006, 2: 259-269. (Pubitemid 47074743)
107. Jiang F, Liu T, Cheng M, Pang XY, Bai ZT, Zhou JJ, et al. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion Buthus martensi Karch. Eur J Pharmacol 2009, 623: 52-64.
108. Guo W, Wang H, Watanabe M, Shimizu K, Zou S, LaGraize SC, et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci 2007, 27: 6006-6018. (Pubitemid 46849761)
109. Smith HS. Activated microglia in nociception. Pain Physician 2010, 13: 295-304.
110. Zhou D, Chen ML, Zhang YQ, Zhao ZQ. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci 2010, 30: 8042-8047.
111. Song P, Zhao ZQ. The involvement of glial cells in the development of morphine tolerance. Neurosci Res 2001, 39: 281-286. (Pubitemid 32186379)
112. Ji RR, Gereau RW, Malcangio M, Strichartz GR. MAP kinase and pain. Brain Res Rev 2009, 60: 135-148.
113. Zhou LJ, Yang T, Wei X, Liu Y, Xin WJ, Chen Y, et al. Brainderived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat. Brain Behav Immun 2011, 25: 322-334.
114. Xu JT, Xin WJ, Wei XH, Wu CY, Ge YX, Liu YL, et al. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp Neurol 2007, 204: 355-365.
115. Kawasaki Y, Zhang L, Cheng JK, Ji RR. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci 2008, 28: 5189-5194.
116. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 2005, 438: 1017-1021. (Pubitemid 43093974)
117. Li J, Xie W, Zhang JM, Baccei ML. Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-alpha. Mol Pain 2009, 5: 10.
118. Zhou LJ, Zhong Y, Ren WJ, Li YY, Zhang T, Liu XG. BDNF induces late-phase LTP of C-fiber evoked field potentials in rat spinal dorsal horn. Exp Neurol 2008, 212: 507-514.
119. Liu YL, Zhou LJ, Hu NW, Xu JT, Wu CY, Zhang T, et al. Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology 2007, 52: 708-715. (Pubitemid 46227465)
120. Park CK, Lu N, Xu ZZ, Liu T, Serhan CN, Ji RR. Resolving TRPV1-and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci 2011, 31: 15072-15085.
121. Bsibsi M, Ravid R, Gveric D, van Noort JM. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 2002, 61: 1013-1021. (Pubitemid 35278723)
122. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004, 173: 3916-3924. (Pubitemid 39280755)
123. Iliev AI, Stringaris AK, Nau R, Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 2004, 18: 412-414.
124. Dalpke AH, Schafer MK, Frey M, Zimmermann S, Tebbe J, Weihe E, et al. Immunostimulatory CpG-DNA activates murine microglia. J Immunol 2002, 168: 4854-4863. (Pubitemid 34495946)
125. Butchi NB, Du M, Peterson KE. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia 2010, 58: 650-664.
126. Qin L, Li G, Qian X, Liu Y, Wu X, Liu B, et al. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPSinduced microglia activation. Glia 2005, 52: 78-84. (Pubitemid 41532140)
127. Clark AK, Staniland AA, Marchand F, Kaan TK, McMahon SB, Malcangio M. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci 2010, 30: 573-582.
128. Sugama S, Takenouchi T, Fujita M, Conti B, Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol 2009, 207: 24-31.
129. Cao L, Tanga FY, Deleo JA. The contributing role of CD14 in tolllike receptor 4 dependent neuropathic pain. Neuroscience 2009, 158: 896-903.
130. Raghavendra V, Tanga FY, Deleo JA. Complete Freunds adjuvantinduced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. Eur J Neurosci 2004, 20: 467-473. (Pubitemid 38969631)
131. Wen YR, Tan PH, Cheng JK, Liu YC, Ji RR. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc 2011, 110: 487-494.
132. Matsui T, Svensson CI, Hirata Y, Mizobata K, Hua XY, Yaksh TL. Release of prostaglandin E (2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth Analg 2010, 111: 554-560.
133. Dityatev A, Rusakov DA. Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol 2011, 21: 353-359.
134. Petzold GC, Murthy VN. Role of astrocytes in neurovascular coupling. Neuron 2011, 71: 782-797.
135. Gao YJ, Ji RR. Activation of JNK pathway in persistent pain. Neurosci Lett 2008, 437: 180-183.
136. Ji RR, Kawasaki Y, Zhuang ZY, Wen YR, Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol 2006, 2: 259-269. (Pubitemid 47074743)
137. Jiang F, Liu T, Cheng M, Pang XY, Bai ZT, Zhou JJ, et al. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion Buthus martensi Karch. Eur J Pharmacol 2009, 623: 52-64.
138. Sun YG, Zhao ZQ, Meng XL, Yin J, Liu XY, Chen ZF. Cellular basis of itch sensation. Science 2009, 325: 1531-1534.
139. Sun YG, Chen ZF. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature 2007, 448: 700-703.
140. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002, 3: 196-200. (Pubitemid 34141451)
141. Kim SJ, Park GH, Kim D, Lee J, Min H, Wall E, et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci U S A 2011, 108: 3371-3376.
142. Schon MP, Schon M, Klotz KN. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7-and TLR8-independent fashion. J Invest Dermatol 2006, 126: 1338-1347. (Pubitemid 43997917)
143. Kaufman EH, Fryer AD, Jacoby DB. Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs. J Allergy Clin Immunol 2011, 127: 462-469.
144. Lai Y, Gallo RL. Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets 2008, 8: 144-155.
145. Miller LS. Toll-like receptors in skin. Adv Dermatol 2008, 24: 71-87.
146. Meyer T, Stockfleth E, Christophers E. Immune response profiles in human skin. Br J Dermatol 2007, 157 (Suppl 2): 1-7. (Pubitemid 350179621)
147. Chen J. History of pain theories. Neurosci Bull 2011, 27: 343-350.
148. Kini SP, Delong LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: The skin equivalent of pain. Arch Dermatol 2011, 147: 1153-1156.
149. Liu Q, Tang Z, Surdenikova L, Kim S, Patel KN, Kim A, et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell 2009, 139: 1353-1365.